1100 13th Street, NW, Suite 1000Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2020The Kiplinger Washington Editors
While the foreseeable future for the broad market may not be clear, there’s one group that still moves independently of stocks as a whole — biotech stocks.
These stocks are still pushed...
Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
Near term, a bias to U.S. stocks makes sense. But long term, you need to capitalize on recoveries in the rest of the world as well.
More Investing News »